Cargando…
Maraviroc in treatment-experienced patients with HIV-1 infection - experience from routine clinical practice
OBJECTIVE: Few data are available about the efficacy of maraviroc (MVC) during routine use. We characterized indications for MVC use and the efficacy of MVC in clinical practice. METHODS: Thirty-two patients treated with MVC at our institution between 2006 and 2009 were included. Genotypic (n = 31)...
Autores principales: | Reuter, S, Braken, P, Jensen, B, Sierra-Aragon, S, Oette, M, Balduin, M, Kaiser, R, Häussinger, D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351991/ https://www.ncbi.nlm.nih.gov/pubmed/20696631 http://dx.doi.org/10.1186/2047-783X-15-6-231 |
Ejemplares similares
-
Ambulatory care for HIV-infected patients: differences in outcomes between hospital-based units and private practices: analysis of the RESINA cohort
por: Oette, Mark, et al.
Publicado: (2013) -
Five-Year Safety Evaluation of Maraviroc in HIV-1–Infected Treatment-Experienced Patients
por: Gulick, Roy M., et al.
Publicado: (2014) -
Maraviroc in the treatment of HIV infection
por: Ray, Neelanjana
Publicado: (2009) -
Pharmacokinetics of maraviroc in plasma and breastmilk in a treatment-experienced perinatally HIV-1-infected woman
por: Feiterna-Sperling, Cornelia, et al.
Publicado: (2019) -
Durability and Effectiveness of Maraviroc-Containing Regimens in HIV-1-Infected Individuals with Virological Failure in Routine Clinical Practice
por: Potard, Valérie, et al.
Publicado: (2015)